A.C. Camargo transformed its fight against claim denials with artificial intelligence.
Einstein uses Rivio to focus on care, with its revenue guaranteed.
Cases
Brazil’s leading hospitals already run on Rivio.
A.C. Camargo transformed its fight against claim denials with artificial intelligence.
Einstein uses Rivio to focus on care, with its revenue guaranteed.
Sírio-Libanês cut manual rework by 80% in the first months.
Advisory Board
The biggest names in healthcare and artificial intelligence. On the same board.
Managing director of Einstein, Henrique Neves has led the institution since the mid-2000s. Before that, he held executive positions at Shell, Brasil Telecom and Varig, combining experience at large corporations with healthcare management.
A Brazilian technology executive and the current Chief Product Officer at Docker, in Silicon Valley. He spent 15 years at Microsoft, led initiatives at Google DeepMind and worked at Meta on product strategy and artificial intelligence APIs, also in California.
A surgeon with a doctorate from the University of São Paulo, Paulo Chapchap led Hospital Sírio-Libanês and is a reference in liver transplantation. He is currently medical director of IEPS and chairs the board of Instituto Todos pela Saúde.
An entrepreneur and software engineer, River Mist was a tech lead at Pinterest and co-founded Weights, a generative AI platform for multimodal creation. After the company was acquired by OpenAI in 2026, he joined OpenAI.
A radiologist and healthcare executive, José Marcelo de Oliveira, known as Jota, has been CEO of Hospital Alemão Oswaldo Cruz since 2021. He previously led A.C.Camargo Cancer Center and built a long career at Grupo Fleury.
A physician trained at the University of São Paulo with a PhD in Medical Informatics, Teresa Sacchetta works at the intersection of healthcare, data and technology. She was CIO of Grupo Fleury and worked at UnitedHealth and Sírio-Libanês. She is currently Vice President of the Conselho Saúde Digital Brasil.
An executive with decades of experience in healthcare, Luiz De Luca was CEO of Hospital 9 de Julho and General Director of Hospital Samaritano. He now serves as a board member and advisor, focused on healthcare management, governance and investment.
A radiologist, executive and researcher, Gustavo Meirelles is Afya’s VP of Medical and Institutional Relations and president of Instituto Afya. He works in healthcare innovation, medical education and artificial intelligence applied to medicine.
Senior partner and founder of Vila Nova, Fernando Carneiro has more than 25 years in executive search. He has led countless searches for CEOs, board members and C-level executives, and previously served as Executive Director of two financial institutions, as a board member of several companies and as Executive Director at Febraban.
Advisory Board
The biggest names in healthcare and artificial intelligence. On the same board.
Managing director of Einstein, Henrique Neves has led the institution since the mid-2000s. Before that, he held executive positions at Shell, Brasil Telecom and Varig, combining experience at large corporations with healthcare management.
A Brazilian technology executive and the current Chief Product Officer at Docker, in Silicon Valley. He spent 15 years at Microsoft, led initiatives at Google DeepMind and worked at Meta on product strategy and artificial intelligence APIs, also in California.
A surgeon with a doctorate from the University of São Paulo, Paulo Chapchap led Hospital Sírio-Libanês and is a reference in liver transplantation. He is currently medical director of IEPS and chairs the board of Instituto Todos pela Saúde.
An entrepreneur and software engineer, River Mist was a tech lead at Pinterest and co-founded Weights, a generative AI platform for multimodal creation. After the company was acquired by OpenAI in 2026, he joined OpenAI.
A radiologist and healthcare executive, José Marcelo de Oliveira, known as Jota, has been CEO of Hospital Alemão Oswaldo Cruz since 2021. He previously led A.C.Camargo Cancer Center and built a long career at Grupo Fleury.
A physician trained at the University of São Paulo with a PhD in Medical Informatics, Teresa Sacchetta works at the intersection of healthcare, data and technology. She was CIO of Grupo Fleury and worked at UnitedHealth and Sírio-Libanês. She is currently Vice President of the Conselho Saúde Digital Brasil.
An executive with decades of experience in healthcare, Luiz De Luca was CEO of Hospital 9 de Julho and General Director of Hospital Samaritano. He now serves as a board member and advisor, focused on healthcare management, governance and investment.
A radiologist, executive and researcher, Gustavo Meirelles is Afya’s VP of Medical and Institutional Relations and president of Instituto Afya. He works in healthcare innovation, medical education and artificial intelligence applied to medicine.
Senior partner and founder of Vila Nova, Fernando Carneiro has more than 25 years in executive search. He has led countless searches for CEOs, board members and C-level executives, and previously served as Executive Director of two financial institutions, as a board member of several companies and as Executive Director at Febraban.
/ 9
Our vision
Healthcare needs engineers.
For decades, the sector was built around more doctors, more beds, more public policy. All of that matters. But what is missing now is different: healthcare needs engineers. People who think in architecture, in scale, in systems. People who look at decades of waste and see a poorly designed system that can be redesigned.
Brazilian hospitals are more operationally complex than banks, and run on a fraction of the engineering capacity. In no other sector is the cost of delay paid in lives. We are building the infrastructure the sector never had. Not another piece of software, but a new layer of intelligence for Brazilian healthcare.
+25%
-12%
Saline sol...
Medication
Added “Saline ...
Claim
Contracts
Action required
Scheduled
In progress
Billed
Released
Paid
Canceled
Action required
Scheduled
Search batches
Batch releasedAll claims were accepted by the payer.
